Drugs / Chloroquine diphosphate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04323527 Comparator | Mar → May 2020 | COVID-19, severe acute respiratory syndrome | Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chloroquine diphosphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04323527 ↗ |
| Route | Oral | “All drugs administered orally” NCT04323527 ↗ |